ATF5 and central nervous system cancer: To test the capacity of Pen-d/n-ATF5-RP to reach and treat primary brain tumors, we used a model in which gliomas are generated by stereotactic injection of PDGF-B-HA/shRNA-p53 retrovirus into the adult mouse brain.